Market Overview:
The global endorphins market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing demand for endorphins in various applications such as institutional pharmacies, retail pharmacies, and online pharmacies. Additionally, the growing awareness about the benefits of using endorphins is also propelling the growth of this market. Based on type, the global endorphins market has been segmented into alpha-endorphins, beta-endorphins, gamma-endorphins and sigma-endorphin. Among these types, alpha-endomorphs held a dominant share in 2017 and is expected to maintain its dominance during the forecast period as well. This can be attributed to their high efficacy in pain relief and other therapeutic applications.
Product Definition:
Endorphins are hormones that are produced by the body in response to pain. They help to block the transmission of pain signals from the spinal cord to the brain and they also produce a feeling of euphoria.
Alpha-Endorphins:
Alpha-endorphins are naturally occurring peptides, which are characterized by a short amino acid sequence. They were first identified in the 1960s and 1970s and since then their role in human health has been extensively studied. Alpha-Endorphins have several functions including neuroprotective, antiinflammatory, apoptosis inhibitory effects on tumor cells; they also enhance the immune system response to infections as well as stress responses.
Beta-Endorphins:
Beta-endorphins are naturally occurring body hormones that bind to the same receptors as do other endorphins. Endorphins are peptides, which are responsible for the body's natural pain relief and functions such as memory, concentration, and stress reduction. Beta-Endorphin is also known as B-endorphin or even morphine like substance (MLS) due to its similar effects in the brain.
Application Insights:
The institutional pharmacies segment dominated the global endorphins market in 2017, accounting for over 60.0% share of the total revenue. The growth can be attributed to factors such as increasing number of hospitals and rising prevalence of chronic diseases. Endorphin-based pharmaceutical products are being used for pain management in various institutions including hospitals and clinics.
The retail pharmacies segment is expected to grow at a significant rate during the forecast period owing to growing awareness about health issues among consumers, especially in emerging markets like India and China where online pharmacy sales are witnessing tremendous growth due to easy access to information through internet cafes and mobile phones respectively. Moreover, governments have made efforts towards improving healthcare facilities at a domestic level by building new medical centers or reconstructing old ones which will eventually boost product demand over the forecast period.
Regional Analysis:
North America dominated the global endorphins market in 2017. The presence of a large number of players coupled with high healthcare expenditure and favorable reimbursement policies are some factors attributing to its largest share. In addition, increasing prevalence of chronic pain conditions is expected to drive the demand for endorphins in this region. For instance, according to a study published by Pain Australia in 2016, approximately 60% population from Australia experienced pain on average at least once per week and over 15% population daily or more often experiencing severe pain.
Asia Pacific is anticipated to be the fastest-growing regional market during the forecast period owing to rising disposable income levels and improving healthcare infrastructure especially in developing countries such as China & India which are major consumers as well as producers of these products like morphine, codeine etc., Furthermore, growing awareness about opioid addiction management along with government initiatives aimed at reducing dependency will fuel growth over the coming years.
Growth Factors:
- Increasing awareness about the health benefits of endorphins is expected to drive their demand in the market.
- Rising prevalence of stress and anxiety is anticipated to fuel the growth of the endorphins market over the forecast period.
- Growing geriatric population is likely to boost demand for endorphin products as they are known to improve cognitive function and memory in seniors.
- Increasing disposable income coupled with rising trend of self-care is projected to propel growth of the global endorphins market during forecast period 2019-2025. 5) The increasing use of complementary and alternative medicine (CAM) therapies that includes therapies involving use of natural products such as herbs, vitamins, minerals, etc., is expected to create lucrative opportunities for players operating in this market over next few years
Scope Of The Report
Report Attributes
Report Details
Report Title
Endorphins Market Research Report
By Type
Alpha-Endorphins, Beta-Endorphins, Gamma-Endorphins, Sigma-Endorphins
By Application
Institutional Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Assertio Therapeutics Inc., Cipher Pharmaceuticals Inc., Endo International Plc, Egalet Corp., Lannett Co. Inc., Pfizer, Johnson & Johnson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
156
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Endorphins Market Report Segments:
The global Endorphins market is segmented on the basis of:
Types
Alpha-Endorphins, Beta-Endorphins, Gamma-Endorphins, Sigma-Endorphins
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Institutional Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Assertio Therapeutics Inc.
- Cipher Pharmaceuticals Inc.
- Endo International Plc
- Egalet Corp.
- Lannett Co. Inc.
- Pfizer
- Johnson & Johnson
Highlights of The Endorphins Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Alpha-Endorphins
- Beta-Endorphins
- Gamma-Endorphins
- Sigma-Endorphins
- By Application:
- Institutional Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Endorphins Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Endorphins are hormones that are produced in the brain and spinal cord. They play an important role in pain relief, stress management, and immune system function.
Some of the major players in the endorphins market are Assertio Therapeutics Inc., Cipher Pharmaceuticals Inc., Endo International Plc, Egalet Corp., Lannett Co. Inc., Pfizer, Johnson & Johnson.
The endorphins market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Endorphins Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Endorphins Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Endorphins Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Endorphins Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Endorphins Market Size & Forecast, 2018-2028
4.5.1 Endorphins Market Size and Y-o-Y Growth
4.5.2 Endorphins Market Absolute $ Opportunity
Chapter 5 Global Endorphins Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Endorphins Market Size Forecast by Type
5.2.1 Alpha-Endorphins
5.2.2 Beta-Endorphins
5.2.3 Gamma-Endorphins
5.2.4 Sigma-Endorphins
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Endorphins Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Endorphins Market Size Forecast by Applications
6.2.1 Institutional Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Endorphins Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Endorphins Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Endorphins Analysis and Forecast
9.1 Introduction
9.2 North America Endorphins Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Endorphins Market Size Forecast by Type
9.6.1 Alpha-Endorphins
9.6.2 Beta-Endorphins
9.6.3 Gamma-Endorphins
9.6.4 Sigma-Endorphins
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Endorphins Market Size Forecast by Applications
9.10.1 Institutional Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Endorphins Analysis and Forecast
10.1 Introduction
10.2 Europe Endorphins Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Endorphins Market Size Forecast by Type
10.6.1 Alpha-Endorphins
10.6.2 Beta-Endorphins
10.6.3 Gamma-Endorphins
10.6.4 Sigma-Endorphins
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Endorphins Market Size Forecast by Applications
10.10.1 Institutional Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Endorphins Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Endorphins Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Endorphins Market Size Forecast by Type
11.6.1 Alpha-Endorphins
11.6.2 Beta-Endorphins
11.6.3 Gamma-Endorphins
11.6.4 Sigma-Endorphins
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Endorphins Market Size Forecast by Applications
11.10.1 Institutional Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Endorphins Analysis and Forecast
12.1 Introduction
12.2 Latin America Endorphins Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Endorphins Market Size Forecast by Type
12.6.1 Alpha-Endorphins
12.6.2 Beta-Endorphins
12.6.3 Gamma-Endorphins
12.6.4 Sigma-Endorphins
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Endorphins Market Size Forecast by Applications
12.10.1 Institutional Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Endorphins Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Endorphins Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Endorphins Market Size Forecast by Type
13.6.1 Alpha-Endorphins
13.6.2 Beta-Endorphins
13.6.3 Gamma-Endorphins
13.6.4 Sigma-Endorphins
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Endorphins Market Size Forecast by Applications
13.10.1 Institutional Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Endorphins Market: Competitive Dashboard
14.2 Global Endorphins Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Assertio Therapeutics Inc.
14.3.2 Cipher Pharmaceuticals Inc.
14.3.3 Endo International Plc
14.3.4 Egalet Corp.
14.3.5 Lannett Co. Inc.
14.3.6 Pfizer
14.3.7 Johnson & Johnson
